MINIRIN Side Effects

6782857-2 | Alcohol Use, Amnesia, Asthenia, Balance Disorder, Chills, Convulsion, Disorientation, Disturbance In Attention, Eye Infection
on Jun 02, 2010 Male patient from UNITED STATES , 29 years of age, was diagnosed with hypertonic bladder and was treated with Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol use, amnesia, asthenia, balance disorder, chills, convulsion, disorientation, disturbance in attention, eye infection (What is eye infection?). Minirin dosage: Nasal. During the same period patient was treated with CLARITIN (View Claritin Review and Claritin Label ), DIURETICS (View Diuretics Review and Diuretics Label ), ZOMIG (View Zomig Review and Zomig Label ), DITROPAN (View Ditropan Review and Ditropan Label ). Patient was hospitalized.

6699321-1 | Blood Osmolarity Decreased, Blood Potassium Decreased, Confusional State, Fall, Haematoma, Hyponatraemia, Off Label Use, Scapula Fracture
Patient was taking Minirin (View Usage). Patient had the following side effects: blood osmolarity decreased, blood potassium decreased, confusional state, fall (What is fall?), haematoma, hyponatraemia, off label use, scapula fracture on Apr 14, 2010 from FRANCE Additional patient health information: Female patient , 92 years of age, was diagnosed with hypertension, nocturia and. Minirin dosage: 60 Ug Sublingual 160 Ug Oral. During the same period patient was treated with KARDEGIC (KARDEGIC) (View Kardegic (kardegic) Review and Kardegic (kardegic) Label ), SIMVASTATINE A (SIMVASTATIN) (View Simvastatine A (simvastatin) Review and Simvastatine A (simvastatin) Label ), CALCIPRAT (CALCIUM CARBONATE) (View Calciprat (calcium Carbonate) Review and Calciprat (calcium Carbonate) Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), NOCTRAN 10 (NOCTRAN 10) (View Noctran 10 (noctran 10) Review and Noctran 10 (noctran 10) Label ). Patient was hospitalized.

6699318-1 | Polydipsia, Weight Decreased
Adverse event was reported on Apr 09, 2010 by a Male patient taking Minirin (View Usage) (Dosage: 960 Ug, 960 Ug Sublingual) was diagnosed with diabetes insipidus (What is diabetes insipidus?) and. Location: FRANCE , child 9 years of age, After Minirin was administered, patient had the following side effects: polydipsia, weight decreased. Patient was hospitalized.

6683128-5 | Atrial Thrombosis, Deep Vein Thrombosis, Pyrexia, Vena Cava Thrombosis
on Mar 30, 2010 Male patient from FRANCE , weighting 30.86 lb, was diagnosed with diabetes mellitus and was treated with Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: atrial thrombosis, deep vein thrombosis (What is deep vein thrombosis?), pyrexia, vena cava thrombosis. Minirin dosage: 0.7 Mg Oral. Patient was hospitalized.


6589017-9 | Convulsion, Hypokalaemia, Hyponatraemia, Vomiting, Water Intoxication
on Jan 29, 2010 Female patient from GERMANY , child 4 years of age, was diagnosed with enuresis and was treated with Minirin (View Usage). Patient had the following side effects: convulsion, hypokalaemia, hyponatraemia, vomiting, water intoxication. Minirin dosage: (2 Mg Oral).

6578715-9 | Abnormal Behaviour, Affect Lability, Apathy, Educational Problem, Hypersomnia, Lethargy, Refusal Of Treatment By Relative, Somnolence
Patient was taking Minirin (View Usage). After Minirin was administered, patient had the following side effects: abnormal behaviour, affect lability, apathy, educational problem, hypersomnia, lethargy, refusal of treatment by relative, somnolence on Jan 18, 2010 from DENMARK Additional patient health information: Male patient , 13 years of age, was diagnosed with enuresis and. Minirin dosage: 120 ?g, Sublingual.

6550273-4 | Intracardiac Thrombus, Pulmonary Embolism, Thrombosis In Device, Venous Thrombosis Limb
Adverse event was reported on Jan 05, 2010 by a Male patient taking Minirin (View Usage) (Dosage: 0.75 Mg, Oral) was diagnosed with diabetes insipidus (What is diabetes insipidus?) and. Location: FRANCE , child 3 years of age, weighting 30.86 lb, Patient experienced the following unwanted or unexpected effects: intracardiac thrombus, pulmonary embolism (What is pulmonary embolism?), thrombosis in device, venous thrombosis limb. Patient was hospitalized.

6528931-7 | Affect Lability, Apathy, Lethargy, Somnolence
on Dec 18, 2009 Male patient from DENMARK , 13 years of age, was diagnosed with enuresis and was treated with Minirin (View Usage). Patient had the following side effects: affect lability, apathy, lethargy, somnolence. Minirin dosage: 120 Ug, Sublingual.

6427112-5 | Epistaxis, Hallucination
on Oct 27, 2009 Female patient from SWEDEN , child 9 years of age, was treated with Minirin (View Usage). After Minirin was administered, patient had the following side effects: epistaxis, hallucination. Minirin dosage: . During the same period patient was treated with SINGULAIR (Dose: Unk) (View Singulair Review and Singulair Label ), ALBUTEROL (Dose: Unk) (View Albuterol Review and Albuterol Label ), PULMICORT (Dose: Unk) (View Pulmicort Review and Pulmicort Label ).

6419742-1 | Convulsion
Patient was taking Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion on Oct 23, 2009 from JAPAN Additional patient health information: Male patient , child 4 years of age, . Minirin dosage: Dose Quantity: .025; Daily Dose Unit: Milligram Per Millilitre. During the same period patient was treated with TOFRANIL (View Tofranil Review and Tofranil Label ), BUP 4 (View Bup-4 Review and Bup-4 Label ). Patient was hospitalized.

6410538-3 | Convulsion
Adverse event was reported on Oct 16, 2009 by a Male patient taking Minirin (View Usage) (Dosage: ) . Location: JAPAN , child 4 years of age, Patient had the following side effects: convulsion. During the same period patient was treated with TOFRANIL (View Tofranil Review and Tofranil Label ), BUP 4 (View Bup-4 Review and Bup-4 Label ). Patient was hospitalized.

6409218-X | Chest Discomfort, Cold Sweat, Dry Throat, Nausea, Palpitations, Tremor
on Oct 14, 2009 Male patient from , 39 years of age, was treated with Minirin (View Usage). After Minirin was administered, patient had the following side effects: chest discomfort, cold sweat, dry throat, nausea (What is nausea?), palpitations, tremor. Minirin dosage: . Patient was hospitalized.

6384103-0 | Abdominal Pain, Agitation, Headache, Hyperhidrosis, Nausea, Off Label Use, Vertigo
on Sep 17, 2009 Male patient from FRANCE , child 11 years of age, weighting 77.16 lb, was diagnosed with enuresis and was treated with Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), agitation, headache (What is headache?), hyperhidrosis, nausea (What is nausea?), off label use, vertigo. Minirin dosage: (20 Ug Nasal) ; (20 Ug Nasal) ; (20 Ug Nasal).

6381912-9 | Abdominal Pain, Agitation, Headache, Hyperhidrosis, Nausea, Off Label Use, Vertigo
Patient was taking Minirin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), agitation, headache (What is headache?), hyperhidrosis, nausea (What is nausea?), off label use, vertigo on Sep 24, 2009 from Additional patient health information: Male patient , child 11 years of age, was diagnosed with enuresis and. Minirin dosage: .

6367843-9 | Abdominal Pain, Agitation, Headache, Hyperhidrosis, Nausea, Off Label Use, Vertigo
Adverse event was reported on Sep 11, 2009 by a Male patient taking Minirin (View Usage) (Dosage: ) was diagnosed with enuresis and. Location: , child 11 years of age, After Minirin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), agitation, headache (What is headache?), hyperhidrosis, nausea (What is nausea?), off label use, vertigo.

6366936-X | Abdominal Pain, Agitation, Headache, Hyperhidrosis, Nausea, Off Label Use, Vertigo
on Sep 02, 2009 Male patient from FRANCE , child 11 years of age, was diagnosed with enuresis and was treated with Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), agitation, headache (What is headache?), hyperhidrosis, nausea (What is nausea?), off label use, vertigo. Minirin dosage: 20 Ug, Nasal.

6204907-4 | Loss Of Consciousness
on Mar 17, 2009 Male patient from DENMARK , 28 years of age, was treated with Minirin (View Usage). Patient had the following side effects: loss of consciousness. Minirin dosage: 0.3 Mg Oral.

6150478-0 | Weight Increased
Patient was taking Minirin (View Usage). After Minirin was administered, patient had the following side effects: weight increased on Apr 02, 2009 from MOROCCO Additional patient health information: Female patient , child 12 years of age, weighting 105.8 lb, was diagnosed with enuresis and. Minirin dosage: .

6150477-9 | Loss Of Consciousness
Adverse event was reported on Mar 31, 2009 by a Male patient taking Minirin (View Usage) (Dosage: ) . Location: CANADA , 28 years of age, Patient experienced the following unwanted or unexpected effects: loss of consciousness.

6145537-2 | Loss Of Consciousness
on Mar 17, 2009 Male patient from DENMARK , 28 years of age, was treated with Minirin (View Usage). Patient had the following side effects: loss of consciousness. Minirin dosage: 0.3 Mg, Oral.

6055460-X | Acute Myocardial Infarction
on Jan 16, 2009 Male patient from , 61 years of age, was diagnosed with prophylaxis, immunosuppression and was treated with Minirin (View Usage). After Minirin was administered, patient had the following side effects: acute myocardial infarction. Minirin dosage: . During the same period patient was treated with IMMUNOSUPPRESSIVE AGENTS (View Immunosuppressive Agents Review and Immunosuppressive Agents Label ). Patient was hospitalized and became disabled.

6024170-7 | Culture Urine Positive, Disorientation, Fall, Hypocalcaemia, Hyponatraemia, Orthostatic Hypotension, Pseudomonas Infection, Somnolence
Patient was taking Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: culture urine positive, disorientation, fall (What is fall?), hypocalcaemia, hyponatraemia, orthostatic hypotension, pseudomonas infection, somnolence on Dec 09, 2008 from FRANCE Additional patient health information: Female patient , 80 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?), hypertension, depression (What is depression?) and. Minirin dosage: 0.2 Mg Po. During the same period patient was treated with COOLMETEC () (OLMESARTAN) (Po) (View Coolmetec () (olmesartan) Review and Coolmetec () (olmesartan) Label ), ATHYMIL (ATHYMIL) (MIANSERIN HYDROCHLORIDE) (60 Mg Po) (View Athymil (athymil) (mianserin Hydrochloride) Review and Athymil (athymil) (mianserin Hydrochloride) Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), FLUNARIZINE DIHYDROCHLORIDE (View Flunarizine Dihydrochloride Review and Flunarizine Dihydrochloride Label ). Patient was hospitalized.

6022779-8 | Fall, Hyponatraemia
Adverse event was reported on Dec 19, 2008 by a Female patient taking Minirin (View Usage) (Dosage: ) was diagnosed with urinary incontinence (What is urinary incontinence?), depression (What is depression?), vertigo and. Location: FRANCE , 80 years of age, Patient had the following side effects: fall (What is fall?), hyponatraemia. During the same period patient was treated with OLMESARTAN/HYDROCHLOROTHIAZIDE (Dose: Unk) (View Olmesartan/hydrochlorothiazide Review and Olmesartan/hydrochlorothiazide Label ), ATHYMIL (View Athymil Review and Athymil Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), SERESTA (View Seresta Review and Seresta Label ), DAFALGAN /00020001/ (Dose: Unk) (View Dafalgan /00020001/ Review and Dafalgan /00020001/ Label ), DITROPAN (View Ditropan Review and Ditropan Label ), RABEPRAZOLE SODIUM (Dose: Unk) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), SIBELIUM /00505202/ (View Sibelium /00505202/ Review and Sibelium /00505202/ Label ). Patient was hospitalized.

6021612-8 | Headache, Loss Of Consciousness
on Dec 17, 2008 Female patient from UNITED KINGDOM , 14 years of age, was diagnosed with turner's syndrome and was treated with Minirin (View Usage). After Minirin was administered, patient had the following side effects: headache (What is headache?), loss of consciousness. Minirin dosage: . During the same period patient was treated with SOMATROPIN (View Somatropin Review and Somatropin Label ).

6012995-3 | Headache, Loss Of Consciousness
on Dec 10, 2008 Female patient from UNITED KINGDOM , 14 years of age, was diagnosed with turner's syndrome and was treated with Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), loss of consciousness. Minirin dosage: . During the same period patient was treated with SOMATROPIN (View Somatropin Review and Somatropin Label ).

5983850-X | Convulsion, Hyponatraemia, Hypotonia, Loss Of Consciousness, Respiratory Arrest
Patient was taking Minirin (View Usage). Patient had the following side effects: convulsion, hyponatraemia, hypotonia, loss of consciousness, respiratory arrest on Nov 28, 2008 from DENMARK Additional patient health information: Female patient , child 7 years of age, was diagnosed with enuresis and. Minirin dosage: . Patient was hospitalized.

5963657-X | Convulsion
Adverse event was reported on Nov 14, 2008 by a Female patient taking Minirin (View Usage) (Dosage: ) . Location: DENMARK , child 7 years of age, After Minirin was administered, patient had the following side effects: convulsion. Patient was hospitalized.

5945862-1 | Ascites, Budd-chiari Syndrome, Hepatomegaly, Oliguria, Vena Cava Thrombosis
on Oct 18, 2008 Male patient from INDIA , child 4 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, budd-chiari syndrome, hepatomegaly, oliguria, vena cava thrombosis. Minirin dosage: 10 Mcg Prn. During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5945860-8 | Ascites, Blood Bilirubin Increased, Budd-chiari Syndrome, Hepatic Enzyme Increased, Hepatic Failure, Hepatosplenomegaly, Jaundice, Renal Failure, Respiratory Distress
on Oct 18, 2008 Female patient from INDIA , child 5 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Minirin (View Usage). Patient had the following side effects: ascites, blood bilirubin increased, budd-chiari syndrome, hepatic enzyme increased, hepatic failure, hepatosplenomegaly, jaundice (What is jaundice?), renal failure, respiratory distress. Minirin dosage: 10 Mcg Prn. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

5941356-8 | Disturbance In Attention, Hyponatraemia, Urinary Tract Infection
Patient was taking Minirin (View Usage). After Minirin was administered, patient had the following side effects: disturbance in attention, hyponatraemia, urinary tract infection (What is urinary tract infection?) on Dec 21, 2007 from FRANCE Additional patient health information: Male patient , 59 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?) and. Minirin dosage: 20 Mcg. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), TRIMEBUTINE MALEATE (View Trimebutine Maleate Review and Trimebutine Maleate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ). Patient was hospitalized.

5939154-4 | Ascites, Budd-chiari Syndrome, Hepatic Enzyme Increased, Hepatic Failure, Hepatosplenomegaly, Renal Failure, Vena Cava Thrombosis
Adverse event was reported on Oct 24, 2008 by a Female patient taking Minirin (View Usage) (Dosage: ) was diagnosed with diabetes insipidus (What is diabetes insipidus?) and. Location: INDIA , child 5 years of age, Patient experienced the following unwanted or unexpected effects: ascites, budd-chiari syndrome, hepatic enzyme increased, hepatic failure, hepatosplenomegaly, renal failure, vena cava thrombosis. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LEOTHYROXINE (View Leothyroxine Review and Leothyroxine Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

5928792-0 | Abdominal Pain, Agitation, Brain Oedema, Hepatocellular Injury, Hyponatraemia, Incorrect Dose Administered, Intracranial Pressure Increased, Liver Injury, Pyrexia
on Feb 26, 2008 Male patient from SWITZERLAND , child 9 years of age, was diagnosed with enuresis and was treated with Minirin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), agitation, brain oedema, hepatocellular injury, hyponatraemia, incorrect dose administered, intracranial pressure increased, liver injury, pyrexia. Minirin dosage: 20 Mcg/20 Mcg/40 Mcg/20 Mcg;in. Patient was hospitalized.

5915019-9 | Hyponatraemia
on Sep 15, 2008 Female patient from CANADA , 75 years of age, was diagnosed with nocturia and was treated with Minirin (View Usage). After Minirin was administered, patient had the following side effects: hyponatraemia. Minirin dosage: Po. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

5914945-4 | Fall, Hyponatraemia
Patient was taking Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hyponatraemia on Oct 03, 2008 from CANADA Additional patient health information: Female patient , 75 years of age, was diagnosed with nocturia, atrial fibrillation (What is atrial fibrillation?), hypertension, osteoporosis (What is osteoporosis?), depression (What is depression?) and. Minirin dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MICARDIS HCT (View Micardis Hct Review and Micardis Hct Label ), RALOXIFENE HYDROCHLORIDE (View Raloxifene Hydrochloride Review and Raloxifene Hydrochloride Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

5911770-5 | Fall, Hyponatraemia, Off Label Use
Adverse event was reported on Sep 16, 2008 by a Female patient taking Minirin (View Usage) (Dosage: 10 Mcg In) was diagnosed with micturition urgency, depression (What is depression?), anxiety (What is anxiety?) and. Location: FRANCE , 92 years of age, Patient had the following side effects: fall (What is fall?), hyponatraemia, off label use. During the same period patient was treated with NORSET (NORSET) (MIRTAZAPINE) (1 Tablet(s) Po) (View Norset (norset) (mirtazapine) Review and Norset (norset) (mirtazapine) Label ), INEXIUM (INEXIUM /01479302/) (ESOMEPRAZOLE MAGNESIUM) (20 Mg Po) (View Inexium (inexium /01479302/) (esomeprazole Magnesium) Review and Inexium (inexium /01479302/) (esomeprazole Magnesium) Label ), RIVOTRIL (RIVOTRIL) (CLONAZEPAM) (10 Mg Po) (View Rivotril (rivotril) (clonazepam) Review and Rivotril (rivotril) (clonazepam) Label ), RISPERDAL (1 Mg Po) (View Risperdal Review and Risperdal Label ), TROSPIUM CHLORIDE (View Trospium Chloride Review and Trospium Chloride Label ), ACETYLSALICYLATE LYSINE (View Acetylsalicylate Lysine Review and Acetylsalicylate Lysine Label ), MACROGOL (View Macrogol Review and Macrogol Label ), SODIUM CHLORIDE INJ (View Sodium Chloride Inj Review and Sodium Chloride Inj Label ).

5908876-3 | Balance Disorder, Hyponatraemia, Off Label Use
on Sep 26, 2008 Female patient from FRANCE , 92 years of age, was diagnosed with depression (What is depression?), anxiety (What is anxiety?) and was treated with Minirin (View Usage). After Minirin was administered, patient had the following side effects: balance disorder, hyponatraemia, off label use. Minirin dosage: . During the same period patient was treated with NORSET (Dose: 1 Tbl) (View Norset Review and Norset Label ), NEXIUM (View Nexium Review and Nexium Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), TROSPIUM CHLORIDE (View Trospium Chloride Review and Trospium Chloride Label ), ACETYLSALICYLATE LYSINE (View Acetylsalicylate Lysine Review and Acetylsalicylate Lysine Label ), MACROGOL (View Macrogol Review and Macrogol Label ), SODIUM CHLORIDE 0.9% (View Sodium Chloride 0.9% Review and Sodium Chloride 0.9% Label ).

5902596-7 | Abdominal Pain, Brain Oedema, Clonus, Coma, Convulsion, Hypertonic Bladder, Hyponatraemia, Incorrect Dose Administered
on Apr 13, 2007 Male patient from FRANCE , child 6 years of age, was diagnosed with enuresis and was treated with Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), brain oedema, clonus, coma, convulsion, hypertonic bladder, hyponatraemia, incorrect dose administered. Minirin dosage: 60 Mcg/40 Mcg In. During the same period patient was treated with OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ). Patient was hospitalized.

5901797-1 | Confusional State, Hyponatraemia, Palpitations
Patient was taking Minirin (View Usage). Patient had the following side effects: confusional state, hyponatraemia, palpitations on Dec 01, 2006 from NEW ZEALAND Additional patient health information: Male patient , 80 years of age, was diagnosed with nocturia and. Minirin dosage: In. Patient was hospitalized.

5901001-4 | Agitation, Hallucinations, Mixed, Psychotic Disorder
Adverse event was reported on Sep 17, 2007 by a Female patient taking Minirin (View Usage) (Dosage: 0.6 Mg Po) was diagnosed with enuresis and. Location: IRELAND , 13 years of age, After Minirin was administered, patient had the following side effects: agitation, hallucinations, mixed, psychotic disorder (What is psychotic disorder?). Patient was hospitalized.

5900991-3 | Coma, Hyponatraemia, Water Intoxication
on Sep 19, 2007 Female patient from NORWAY , 63 years of age, was diagnosed with nocturia and was treated with Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: coma, hyponatraemia, water intoxication. Minirin dosage: 120 Mcg Sl. Patient was hospitalized.

5900858-0 | Blood Osmolarity Decreased, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Overdose, Somnolence, Upper Respiratory Tract Infection
on Feb 26, 2008 Male patient from SWITZERLAND , 58 years of age, was diagnosed with pituitary tumour benign and was treated with Minirin (View Usage). Patient had the following side effects: blood osmolarity decreased, hyponatraemia, inappropriate antidiuretic hormone secretion, overdose, somnolence, upper respiratory tract infection. Minirin dosage: 0.3 Mg. During the same period patient was treated with CORTISONE ACETATE (View Cortisone Acetate Review and Cortisone Acetate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TESTOSTERONE ENANTHATE (View Testosterone Enanthate Review and Testosterone Enanthate Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ).

5894690-4 | Haematuria, Post Streptococcal Glomerulonephritis, Pyrexia
Patient was taking Minirin (View Usage). After Minirin was administered, patient had the following side effects: haematuria, post streptococcal glomerulonephritis, pyrexia on Jan 07, 2008 from FRANCE Additional patient health information: Male patient , child 6 years of age, was diagnosed with enuresis and. Minirin dosage: Sl. Patient was hospitalized.

5894687-4 | Extrasystoles
Adverse event was reported on Aug 07, 2007 by a Male patient taking Minirin (View Usage) (Dosage: 0.2 Mg Po) was diagnosed with enuresis and. Location: GERMANY , child 8 years of age, Patient experienced the following unwanted or unexpected effects: extrasystoles.

5893554-X | Convulsion, Hyponatraemia, Loss Of Consciousness, Urine Sodium Increased
on Dec 25, 2007 Male patient from ISRAEL , child 12 years of age, was diagnosed with enuresis and was treated with Minirin (View Usage). Patient had the following side effects: convulsion, hyponatraemia, loss of consciousness, urine sodium increased. Minirin dosage: 0.2 Mg Po. Patient was hospitalized.

5892935-8 | Arrhythmia, Extrasystoles
on Aug 31, 2007 Male patient from GERMANY , child 8 years of age, was diagnosed with enuresis and was treated with Minirin (View Usage). After Minirin was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), extrasystoles. Minirin dosage: 0.2 Mg Po.

5892927-9 | Hypertension
Patient was taking Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension on Jun 27, 2006 from UNITED KINGDOM Additional patient health information: Male patient , child 9 years of age, was diagnosed with enuresis and. Minirin dosage: 0.4 Mg Po.

5892924-3 | Depression, Self Esteem Decreased, Tearfulness
Adverse event was reported on Mar 05, 2008 by a Female patient taking Minirin (View Usage) (Dosage: 120 Mcg Sl) was diagnosed with enuresis and. Location: UNITED KINGDOM , child 7 years of age, Patient had the following side effects: depression (What is depression?), self esteem decreased, tearfulness.

5892809-2 | Alcohol Use, Coma, Hyponatraemia, Water Intoxication
on Aug 31, 2007 Female patient from NORWAY , 63 years of age, was diagnosed with incontinence and was treated with Minirin (View Usage). After Minirin was administered, patient had the following side effects: alcohol use, coma, hyponatraemia, water intoxication. Minirin dosage: . Patient was hospitalized.

5892225-3 | Concussion, Fall, Hyponatraemia
on Sep 29, 2006 Female patient from DENMARK , 84 years of age, was diagnosed with nocturia and was treated with Minirin (View Usage). Patient experienced the following unwanted or unexpected effects: concussion (What is concussion?), fall (What is fall?), hyponatraemia. Minirin dosage: Po. Patient was hospitalized.

5892223-X | Neoplasm Progression
Patient was taking Minirin (View Usage). Patient had the following side effects: neoplasm progression on Sep 28, 2006 from FRANCE Additional patient health information: Male patient , child 3 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?), hypopituitarism and. Minirin dosage: 3 Tablet(s); Po. During the same period patient was treated with NORDITROPIN (0.3 Mg; Sc) (View Norditropin Review and Norditropin Label ), L THYROXINE (L THYROXINE /00068001/) (Po) (View L-thyroxine (l-thyroxine /00068001/) Review and L-thyroxine (l-thyroxine /00068001/) Label ), HYDROCORTISONE (Po) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.